Analytical Data
-
基因名
PPAP2A
- Application
-
别名
PLPP1; LPP1; PPAP2A; Phospholipid phosphatase 1; Lipid phosphate phosphohydrolase 1; PAP2-alpha; Phosphatidate phosphohydrolase type 2a; Phosphatidic acid phosphatase 2a; PAP-2a; PAP2a
-
种属
Human
-
表达系统
E. coli
-
标签
GST-tag at N-terminal
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
O14494
-
表达区间
1-284 aa
-
氨基酸序列
MFDKTRLPYVALDVLCVLLAGLPFAILTSRHTPFQRGVFCNDESIKYPYKEDTIPYALLGGIIIPFSIIVIILGETLSVYCNLLHSNSFIRNNYIATIYKAIGTFLFGAAASQSLTDIAKYSIGRLRPHFLDVCDPDWSKINCSDGYIEYYICRGNAERVKEGRLSFYSGHSSFSMYCMLFVALYLQARMKGDWARLLRPTLQFGLVAVSIYVGLSRVSDYKHHWSDVLTGLIQGALVAILVAVYVSDFFKERTSFKERKEEDSHTTLHETPTTGNHYPSNHQP
-
分子量
56.98 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PPAP2A, or Phosphatidylinositol-Phosphate Phosphatase Type 2A, is a crucial enzyme implicated in the regulation of cellular signaling pathways through the modulation of phosphoinositide levels. This protein plays a significant role in various physiological processes, including cell growth, differentiation, and apoptosis, by dephosphorylating specific phosphoinositides such as PIP2 and PIP3. Dysregulation of PPAP2A activity has been associated with several pathological conditions, including cancer, cardiovascular diseases, and neurological disorders. As researchers explore potential therapeutic targets, the recombinant expression of PPAP2A has garnered attention for its utility in functional studies and drug development. Producing PPAP2A as a recombinant protein allows for detailed biochemical and biophysical characterization, enabling a better understanding of its enzymatic mechanisms and interactions with other signaling molecules. By harnessing advances in protein engineering and expression systems, scientists aim to elucidate the precise roles of PPAP2A in health and disease, potentially leading to innovative approaches in treating conditions linked to its dysfunction. This research not only enhances fundamental knowledge of cellular signaling but also opens new avenues for therapeutic intervention in diseases where PPAP2A is a key player.
